Michael Entzeroth

3.7k total citations
52 papers, 3.0k citations indexed

About

Michael Entzeroth is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Michael Entzeroth has authored 52 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 21 papers in Cellular and Molecular Neuroscience and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Michael Entzeroth's work include Receptor Mechanisms and Signaling (22 papers), Neuropeptides and Animal Physiology (18 papers) and Renin-Angiotensin System Studies (8 papers). Michael Entzeroth is often cited by papers focused on Receptor Mechanisms and Signaling (22 papers), Neuropeptides and Animal Physiology (18 papers) and Renin-Angiotensin System Studies (8 papers). Michael Entzeroth collaborates with scholars based in Germany, Singapore and United States. Michael Entzeroth's co-authors include Wolfgang Wienen, Henri Doods, K Rudolf, Wolfgang Eberlein, Wolfhard Engel, H. Wieland, Norbert Hauel, Annette G. Beck‐Sickinger, Dongmei Wu and Berthold Narr and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and The Journal of Organic Chemistry.

In The Last Decade

Michael Entzeroth

51 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Entzeroth Germany 29 1.5k 1.3k 433 401 357 52 3.0k
Lorella M.T. Canzoniero Italy 40 3.0k 2.0× 2.3k 1.8× 227 0.5× 1.2k 3.0× 117 0.3× 103 5.8k
Jason E. Savage United States 19 1.3k 0.9× 553 0.4× 135 0.3× 377 0.9× 93 0.3× 38 2.6k
Jiangping Xu China 36 2.0k 1.3× 609 0.5× 143 0.3× 601 1.5× 100 0.3× 125 3.8k
Hagit Eldar-Finkelman Israel 41 3.5k 2.3× 699 0.6× 130 0.3× 1.0k 2.6× 147 0.4× 83 5.3k
Vera Ádám‐Vizi Hungary 41 3.7k 2.5× 1.2k 1.0× 116 0.3× 1.1k 2.7× 96 0.3× 104 5.8k
Ikuko Miyazaki Japan 39 1.4k 1.0× 1.6k 1.2× 94 0.2× 548 1.4× 181 0.5× 131 4.7k
Biancamaria Longoni Italy 25 785 0.5× 611 0.5× 71 0.2× 224 0.6× 147 0.4× 65 2.0k
Arata Ichiyama Japan 32 3.4k 2.2× 1.4k 1.1× 153 0.4× 482 1.2× 52 0.1× 119 4.5k
G. Zürcher Switzerland 27 888 0.6× 553 0.4× 305 0.7× 318 0.8× 398 1.1× 42 3.0k
Sergio Bova Italy 25 1.8k 1.2× 798 0.6× 711 1.6× 348 0.9× 47 0.1× 98 3.1k

Countries citing papers authored by Michael Entzeroth

Since Specialization
Citations

This map shows the geographic impact of Michael Entzeroth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Entzeroth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Entzeroth more than expected).

Fields of papers citing papers by Michael Entzeroth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Entzeroth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Entzeroth. The network helps show where Michael Entzeroth may publish in the future.

Co-authorship network of co-authors of Michael Entzeroth

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Entzeroth. A scholar is included among the top collaborators of Michael Entzeroth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Entzeroth. Michael Entzeroth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Entzeroth, Michael, et al.. (2015). Angiotensin II receptor antagonists. Elsevier eBooks. 43(2A). 466–471.
2.
Mitchell, Wayne, Colin Breen, & Michael Entzeroth. (2007). Genomics as knowledge enterprise: Implementing an electronic research habitat at the Biopolis Experimental Therapeutics Center. Biotechnology Journal. 3(3). 364–369. 2 indexed citations
3.
Stünkel, Walter, Bee Keow Peh, Yong Tan, et al.. (2007). Function of the SIRT1 protein deacetylase in cancer. Biotechnology Journal. 2(11). 1360–1368. 197 indexed citations
4.
Wang, Xukun, Yong Tan, Anders Poulsen, et al.. (2006). SIRT1 Modulating Compounds from High-Throughput Screening as Anti-Inflammatory and Insulin-Sensitizing Agents. SLAS DISCOVERY. 11(8). 959–967. 113 indexed citations
5.
Doods, Henri, Dongmei Wu, Michael Entzeroth, et al.. (2000). Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. British Journal of Pharmacology. 129(3). 420–423. 386 indexed citations
6.
Rist, Beate, et al.. (1999). CGRP 27–37 analogues with high affinity to the CGRP1 receptor show antagonistic properties in a rat blood flow assay. Regulatory Peptides. 79(2-3). 153–158. 24 indexed citations
7.
Rist, Beate, Michael Entzeroth, & Annette G. Beck‐Sickinger. (1998). From Micromolar to Nanomolar Affinity:  A Systematic Approach To Identify the Binding Site of CGRP at the Human Calcitonin Gene-Related Peptide 1 Receptor. Journal of Medicinal Chemistry. 41(1). 117–123. 59 indexed citations
8.
Doods, Henri, et al.. (1994). Pharmacological profile of selective muscarinic receptor antagonists on guinea-pig ileal smooth muscle. European Journal of Pharmacology. 253(3). 275–281. 32 indexed citations
9.
10.
Rudolf, K, Wolfgang Eberlein, Wolfhard Engel, et al.. (1994). The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226. European Journal of Pharmacology. 271(2-3). R11–R13. 337 indexed citations
11.
Doods, Henri, et al.. (1993). Characterization of muscarinic receptors in guinea-pig uterus. European Journal of Pharmacology. 250(2). 223–230. 64 indexed citations
12.
Ries, Uwe J., Gerhard Mihm, Berthold Narr, et al.. (1993). 6-Substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: synthesis, biological activity, and structure-activity relationships. Journal of Medicinal Chemistry. 36(25). 4040–4051. 174 indexed citations
13.
Doods, H. N., Rémi Quirion, Gerhard Mihm, et al.. (1993). Therapeutic potential of CNS-active M2 antagonists: Novel structures and pharmacology. Life Sciences. 52(5-6). 497–503. 58 indexed citations
14.
Wienen, Wolfgang, et al.. (1992). Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.. Molecular Pharmacology. 41(6). 1081–1088. 54 indexed citations
15.
Zhang, Jisi, Michael Entzeroth, Wolfgang Wienen, & J. C. A. van Meel. (1992). Characterization of BIBS 39 and BIBS 222: two new nonpeptide angiotensin II receptor antagonists. European Journal of Pharmacology. 218(1). 35–41. 27 indexed citations
16.
Doods, Henri, Michael Entzeroth, & Norbert Michael Mayer. (1991). Cardioselectivity of AQ-RA 741, a novel tricyclic antimuscarinic drug. European Journal of Pharmacology. 192(1). 147–152. 30 indexed citations
17.
Entzeroth, Michael & N. Michael Mayer. (1991). The Binding of [3H]af-dx 384 to Rat Ileal Smooth Muscle Muscarinic Receptors. Journal of Receptor Research. 11(1-4). 141–152. 13 indexed citations
18.
Schinke, Martina, H. N. Doods, Detlev Ganten, Wolfgang Wienen, & Michael Entzeroth. (1991). Characterization of rat intestinal anglotensin II receptors. European Journal of Pharmacology. 204(2). 165–170. 28 indexed citations
19.
Entzeroth, Michael & Norbert Michael Mayer. (1990). Labeling of rat heart muscarinic receptors using the new M2 selective antagonist [3H]AF-DX 384. Biochemical Pharmacology. 40(7). 1674–1676. 25 indexed citations
20.
Moore, Richard E. & Michael Entzeroth. (1988). Majusculamide D and deoxymajusculamide D, two cytotoxins from Lyngbya majuscula. Phytochemistry. 27(10). 3101–3103. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lorella M.T. Canzoniero Breakdown of academic impact, for papers by Jason E. Savage Breakdown of academic impact, for papers by Jiangping Xu Breakdown of academic impact, for papers by Hagit Eldar-Finkelman Breakdown of academic impact, for papers by Vera Ádám‐Vizi Breakdown of academic impact, for papers by Ikuko Miyazaki Breakdown of academic impact, for papers by Biancamaria Longoni Breakdown of academic impact, for papers by Arata Ichiyama Breakdown of academic impact, for papers by G. Zürcher Breakdown of academic impact, for papers by Sergio Bova
Rankless by CCL
2026